GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » Land And Improvements

Kanabo Group (LSE:KNB) Land And Improvements : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group Land And Improvements?

Kanabo Group's land and improvements for the quarter that ended in Dec. 2023 was £0.00 Mil.


Kanabo Group Land And Improvements Historical Data

The historical data trend for Kanabo Group's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group Land And Improvements Chart

Kanabo Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Land And Improvements
Get a 7-Day Free Trial - - - - -

Kanabo Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kanabo Group Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Kanabo Group (LSE:KNB) Business Description

Traded in Other Exchanges
Address
137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ
Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group (LSE:KNB) Headlines

No Headlines